Detalhe da pesquisa
1.
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma.
J Clin Oncol
; 41(3): 528-540, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998300
2.
Observational study of talimogene laherparepvec use for melanoma in clinical practice in the United States (COSMUS-1).
Melanoma Manag
; 6(2): MMT19, 2019 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31406563